The University of Utah School of Medicine is located on the upper campus of the University of Utah in Salt Lake City, Utah. It was founded in 1905 and is currently the only MD-granting medical school in the state of Utah.

During the past decade, University of Utah School of Medicine conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 39 clinical trials were completed, i.e. on average, 90.7% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 18 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Utah School of Medicine" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Ipsen" with 6 trials sponsored, "Biogen" with 5 trials sponsored, "Celgene" with 5 trials sponsored and "Hoffmann-La Roche" with 5 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 48 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Utah School of Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 4 trials as a collaborator, "National Marrow Donor Program" with 3 trials as a collaborator and "Bristol-Myers Squibb" with 2 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "University of Utah School of Medicine" are "HIV Infections" (12 trials), "Crohn Disease" (5 trials), "Eosinophilic Esophagitis" (5 trials), "Spinal Muscular Atrophy" (4 trials) and "Major Depressive Disorder" (3 trials). Many other conditions were trialed in "University of Utah School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Utah School of Medicine" are "Drug" (68 trials), "Biological" (13 trials), "Other" (7 trials), "Device" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Zidovudine" (7 trials), "Botulinum toxin type A" (4 trials), "Etrolizumab" (4 trials) and "Didanosine" (3 trials). Other intervention names were less common.

The vast majority of trials in "University of Utah School of Medicine" are 75 trials for "All" genders, 7 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "University of Utah School of Medicine". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 57 completed trials in University of Utah School of Medicine, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in University of Utah School of Medicine, 10 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 13 trials that are defined as “Not Applicable".